For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy.

TitleUse of Curcumin in Multiple Myeloma patients intolerant of steroid therapy.
Publication TypeJournal Article
Year of Publication2020
AuthorsRamakrishna R, Diamond TH, Alexander W, Manoharan A, Golombick T
JournalClin Case Rep
Volume8
Issue4
Pagination739-744
Date Published2020 Apr
ISSN2050-0904
Abstract

Curcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression-free survival without the adverse effects of steroid-based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug or proteasome inhibitor.

DOI10.1002/ccr3.2735
Alternate JournalClin Case Rep
PubMed ID32274049
PubMed Central IDPMC7141712